Search for Clinical Trial Results

Sponsored By

Genomic Instability - 18 Studies Found

Status Study
Completed Study Name: Does Sevoflurane Cause Genomic Damage
Condition: Anesthesia; Adverse Effect
Date: 2017-03-20
Interventions:
  • Drug: Sevoflurane The patients
Active, not recruiting Study Name: Safety of Ginkgo Biloba Leaf Extract
Condition: Healthy
Date: 2016-12-20
Interventions:
  • Dietary Supplement: Gingko Biloba Extract

Recruiting Study Name: Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma
Condition: Metastatic Colorectal Adenocarcinoma
Date: 2012-07-09
Interventions:
  • Drug: Gemcitabine intravenous

Completed Study Name: Tissue Microarrays (TMAs) Construction in Lung Cancer Samples
Condition: Lung Cancer
Date: 2017-04-21
Not yet recruiting Study Name: Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
Condition:
  • Microsatellite Stable Colorectal Cancer
  • Pancreatic Cancer

  • Date: 2017-04-03
    Interventions:
    • Drug: Nivolumab The antibodies
Not yet recruiting Study Name: Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
Condition:
  • Carcinoma, Renal Cell
  • Head and Neck Neoplasm
  • Skin Neoplasm
    Date: 2017-01-02
    Interventions: Drug: Nivolumab Treatment Other Name: Opdivo
Not yet recruiting Study Name: Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Microsatellite Instability-High Metastatic Colorectal Cancer
Condition:
  • Colorectal Adenocarcinoma
  • High-Frequency Microsatellite Instability
  • Drug: Atezolizumab Given IV
Not yet recruiting Study Name: Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Condition:
  • Castration Levels of Testosterone
  • Hormone-Resistant Prostate Cancer
  • Biological: Durvalumab Given I
Not yet recruiting Study Name: Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability
Condition:
  • Colon Adenocarcinoma
  • DNA Repair Disorder
  • Lynch Syndrome Date: 2016-09-22
    Interventions:
    • Drug: Atezolizumab Given IV
Completed Study Name: A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer
Condition:
  • MSI-L/MSS
  • Stage II Colon Cancer

Date: 2016-08-01
Interventions: Drug: tegafur-uracil
Next >>>